Nasdaq · CIK 0001145197 · SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
INSULET CORPORATION
PODD chart by TradingView
PRICE HISTORY
LIVE · NASDAQPODD chart by TradingView
- REVENUE FY2025 ENDED DEC 2025
- $2.7B
- EBITDA
- $0.6B
- FREE CASH FLOW
- $0.4B
- EPS
- $3.44
- GROSS MARGIN
- 71.63%
- ROIC
- —
Q2 FY26ENDED JUN 2026HOVERDRAG ACROSS ANY CHART TO SCRUB ALL 24 · 40 QUARTERS SHOWNVALUATIONGROWTHPROFITABILITY & RETURNSCASH & CAPITALBALANCE SHEET
VALUATION
what you pay for a unit of the business7 CHARTS⤢
P / E RATIO (TTM)
28.2x
-98%28.2x37263.0x
⤢
P / SALES (TTM)
3.5x
-41%3.5x19.1x
⤢
P / BOOK
7.4x
-78%7.4x176.6x
⤢
EV / EBITDA (TTM)
—
-79%121.1x1155.3x
⤢
EV / REVENUE (TTM)
—
+204%6.4x19.5x
⤢
FCF YIELD (TTM)
2.78%
+3.1pp-2.51%2.82%
⤢
DIVIDEND YIELD (TTM)
—
GROWTH
is the business getting bigger5 CHARTS⤢
REVENUE
$0.8B
+745%⤢
EBITDA (DERIVED)
$0.2B
+5654%⤢
NET INCOME
$0.1B
+$0.1B⤢
EPS (DILUTED)
$1.37
+$1.53⤢
REVENUE GROWTH YOY
23.51%
-9.4pp13.22%42.52%
PROFITABILITY & RETURNS
what survives to the bottom, and what it earns on capital4 CHARTS⤢
FCF MARGIN
6.97%
+18.2pp-47.07%27.41%
⤢
RETURN ON CAPITAL
—
+23.2pp-26.36%4.26%
⤢
RETURN ON EQUITY (TTM)
26.39%
+98.7pp-72.34%39.59%
MARGIN FUNNEL
every line is a share of the same revenue, so they read on one scale — the gaps are what each layer takes out, and net rises above operating when income arrives from outside the businessGROSS MARGIN70.18%
OPERATING MARGIN16.18%
NET MARGIN11.85%
FCF MARGIN6.97%
CASH & CAPITAL
where the money actually goes5 CHARTS⤢
FREE CASH FLOW
$0.1B
+$0.1B⤢
STOCK-BASED COMP
$0.0B
+223%⤢
CAPITAL EXPENDITURE
$0.0B
+144%⤢
SHARES OUTSTANDING
0.07B
+21%⤢
DIVIDEND / SHARE
—
BALANCE SHEET
how much cushion there is3 CHARTS⤢
CASH & EQUIVALENTS
—
+298%⤢
TOTAL DEBT
$0.0B
-94%⤢
DEBT / EBITDA (TTM)
0.0x
-100%0.0x115.8x
OWNERSHIP
10 LARGEST HOLDERS · WHO OWNS THE FLOATINSTITUTIONS 105.92%INSIDERS 0.33%OTHER / RETAIL 0.00%1,121 INSTITUTIONAL FILERS
| HOLDER | % HELD | SHARES | VALUE | CHANGE |
|---|---|---|---|---|
| Blackrock Inc. | 9.19% | 6.4M | $900.1M | -3.1% |
| Vanguard Capital Management LLC | 6.60% | 4.6M | $646.5M | NEW |
| FMR, LLC | 5.73% | 4.0M | $561.1M | -37.2% |
| Vanguard Portfolio Management LLC | 4.97% | 3.4M | $487.0M | NEW |
| State Street Corporation | 4.39% | 3.0M | $429.5M | -3.6% |
| BAILLIE GIFFORD & CO | 2.94% | 2.0M | $288.3M | +0.6% |
| Geode Capital Management, LLC | 2.92% | 2.0M | $286.0M | +1.0% |
| T. Rowe Price Investment Management, Inc. | 2.62% | 1.8M | $256.3M | +537101.8% |
| Capital Research Global Investors | 2.41% | 1.7M | $235.7M | -62.1% |
| AQR Capital Management, LLC | 2.31% | 1.6M | $225.7M | +248.2% |
AS OF 2026-03-31 · MOST RECENT 13F FILINGS
SOURCE → 10-K · 10-Q · 8-K / GUIDANCE · ALL FILINGS
FILING DATA AS OF 2026-08-10. Figures are derived from public SEC EDGAR filings (40most recent quarters shown, Q4 implied as full-year minus Q1-Q3). Valuation multiples use each period’s fiscal period-end close. Live price charts and quotes are provided by TradingView. This page is informational only — it is not investment advice, and figures are not warranted for accuracy. EBITDA is not a GAAP measure; it is derived as operating income + D&A. Verify against the linked source filing before relying on any number here.
FILING DATA AS OF 2026-08-10. Figures are derived from public SEC EDGAR filings (40most recent quarters shown, Q4 implied as full-year minus Q1-Q3). Valuation multiples use each period’s fiscal period-end close. Live price charts and quotes are provided by TradingView. This page is informational only — it is not investment advice, and figures are not warranted for accuracy. EBITDA is not a GAAP measure; it is derived as operating income + D&A. Verify against the linked source filing before relying on any number here.